In 2018, thanks to a multiomics analysis by Kamoun A. et al. [9], we identified three distinct molecular transcriptomic signatures associated with prostate cancer aggressiveness: aggressive ERG-dependent (S1), aggressive ERG-independent (S3), and non-aggressive (S2). Here, ERG is linked to prostate cancer.